Mottola Frank

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

4
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. OfficerOption exercisenothing paid1,650 sharesAug 14, 2026SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. Officernothing paidExercise · Aug 14Option exercise1,650Aug 14, 2026
SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. OfficerAdministrative$37,116797 sharesAug 14, 2026SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. Officer$37,116Admin · Aug 14Administrative797Aug 14, 2026
SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. OfficerOption exercisenothing paid1,650 sharesAug 14, 2026SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. Officernothing paidExercise · Aug 14Option exercise1,650Aug 14, 2026
SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. OfficerAwardnothing paid1,650 sharesJul 31, 2026SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Tech. Ops. Officernothing paidAward · Jul 31Award1,650Jul 31, 2026